×
S&P 500   3,816.89 (-0.12%)
DOW   30,999.34 (+0.17%)
QQQ   283.99 (+0.16%)
AAPL   139.94 (+1.82%)
MSFT   261.56 (+1.98%)
META   163.44 (+1.72%)
GOOGL   2,241.55 (+0.06%)
AMZN   109.46 (+1.92%)
TSLA   672.61 (-3.64%)
NVDA   155.27 (-2.85%)
NIO   21.43 (-4.16%)
BABA   115.20 (-1.34%)
AMD   77.53 (-4.02%)
MU   56.17 (-2.92%)
CGC   3.51 (-2.77%)
T   20.73 (+0.58%)
GE   63.90 (-3.01%)
F   11.52 (-2.46%)
DIS   94.99 (-0.97%)
AMC   13.29 (-0.67%)
PFE   51.10 (+0.87%)
PYPL   71.50 (-0.45%)
NFLX   176.48 (-1.74%)
S&P 500   3,816.89 (-0.12%)
DOW   30,999.34 (+0.17%)
QQQ   283.99 (+0.16%)
AAPL   139.94 (+1.82%)
MSFT   261.56 (+1.98%)
META   163.44 (+1.72%)
GOOGL   2,241.55 (+0.06%)
AMZN   109.46 (+1.92%)
TSLA   672.61 (-3.64%)
NVDA   155.27 (-2.85%)
NIO   21.43 (-4.16%)
BABA   115.20 (-1.34%)
AMD   77.53 (-4.02%)
MU   56.17 (-2.92%)
CGC   3.51 (-2.77%)
T   20.73 (+0.58%)
GE   63.90 (-3.01%)
F   11.52 (-2.46%)
DIS   94.99 (-0.97%)
AMC   13.29 (-0.67%)
PFE   51.10 (+0.87%)
PYPL   71.50 (-0.45%)
NFLX   176.48 (-1.74%)
S&P 500   3,816.89 (-0.12%)
DOW   30,999.34 (+0.17%)
QQQ   283.99 (+0.16%)
AAPL   139.94 (+1.82%)
MSFT   261.56 (+1.98%)
META   163.44 (+1.72%)
GOOGL   2,241.55 (+0.06%)
AMZN   109.46 (+1.92%)
TSLA   672.61 (-3.64%)
NVDA   155.27 (-2.85%)
NIO   21.43 (-4.16%)
BABA   115.20 (-1.34%)
AMD   77.53 (-4.02%)
MU   56.17 (-2.92%)
CGC   3.51 (-2.77%)
T   20.73 (+0.58%)
GE   63.90 (-3.01%)
F   11.52 (-2.46%)
DIS   94.99 (-0.97%)
AMC   13.29 (-0.67%)
PFE   51.10 (+0.87%)
PYPL   71.50 (-0.45%)
NFLX   176.48 (-1.74%)
S&P 500   3,816.89 (-0.12%)
DOW   30,999.34 (+0.17%)
QQQ   283.99 (+0.16%)
AAPL   139.94 (+1.82%)
MSFT   261.56 (+1.98%)
META   163.44 (+1.72%)
GOOGL   2,241.55 (+0.06%)
AMZN   109.46 (+1.92%)
TSLA   672.61 (-3.64%)
NVDA   155.27 (-2.85%)
NIO   21.43 (-4.16%)
BABA   115.20 (-1.34%)
AMD   77.53 (-4.02%)
MU   56.17 (-2.92%)
CGC   3.51 (-2.77%)
T   20.73 (+0.58%)
GE   63.90 (-3.01%)
F   11.52 (-2.46%)
DIS   94.99 (-0.97%)
AMC   13.29 (-0.67%)
PFE   51.10 (+0.87%)
PYPL   71.50 (-0.45%)
NFLX   176.48 (-1.74%)
OTCMKTS:KNWN

Know Labs Stock Forecast, Price & News

$2.18
+0.21 (+10.66%)
(As of 06/28/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.99
$2.71
50-Day Range
$1.40
$2.18
52-Week Range
$1.15
$3.99
Volume
122,964 shs
Average Volume
39,027 shs
Market Capitalization
$95.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
30 days | 90 days | 365 days | Advanced Chart

Receive KNWN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Know Labs and its competitors with MarketBeat's FREE daily newsletter.

KNWN Stock Forecast (MarketRank)

Overall MarketRank

1.99 out of 5 stars

Analyst Opinion: 3.5Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
Know Labs logo

About Know Labs (OTCMKTS:KNWN)

Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.

KNWN Stock News Headlines

Comparing Know Labs (KNWN) and Its Peers
Know Labs (KNWN) versus The Competition Critical Analysis
Head-To-Head Analysis: Know Labs (KNWN) vs. The Competition
Reviewing Know Labs (KNWN) & Its Rivals
Analyzing Know Labs (KNWN) and The Competition
Know Labs (KNWN) vs. Its Competitors Financial Survey
Comparing Know Labs (KNWN) & Its Rivals
Comparing Know Labs (KNWN) & The Competition
Comparing Know Labs (KNWN) and Its Rivals
Head to Head Analysis: Know Labs (KNWN) & Its Rivals
Financial Comparison: Know Labs (KNWN) & The Competition
Know Labs (KNWN) versus The Competition Financial Review
See More Headlines

Industry, Sector and Symbol

Industry
Measuring & controlling devices, not elsewhere classified
Sub-Industry
N/A
Current Symbol
OTCMKTS:KNWN
Employees
12
Year Founded
N/A

Company Calendar

Last Earnings
8/07/2019
Today
6/29/2022
Fiscal Year End
9/30/2022

Price Target and Rating

Average Stock Price Forecast
$7.00
High Stock Price Forecast
$7.00
Low Stock Price Forecast
$7.00
Forecasted Upside/Downside
+221.1%
Consensus Rating
Buy
Rating Score (0-4)
3
Research Coverage
1 Analysts

Profitability

Net Income
$-25.36 million
Pretax Margin
-600.57%

Debt

Sales & Book Value

Annual Sales
$120 thousand
Book Value
$0.04 per share

Miscellaneous

Free Float
24,529,000
Market Cap
$95.49 million
Optionable
Not Optionable
Beta
3.05














Know Labs Frequently Asked Questions

Should I buy or sell Know Labs stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Know Labs in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Know Labs stock.
View analyst ratings for Know Labs
or view top-rated stocks.

What is Know Labs' stock price forecast for 2022?

1 analysts have issued 12-month price targets for Know Labs' shares. Their KNWN stock forecasts range from $7.00 to $7.00. On average, they predict Know Labs' stock price to reach $7.00 in the next year. This suggests a possible upside of 221.1% from the stock's current price.
View analysts' price targets for Know Labs
or view top-rated stocks among Wall Street analysts.

How has Know Labs' stock price performed in 2022?

Know Labs' stock was trading at $1.6975 on January 1st, 2022. Since then, KNWN stock has increased by 28.4% and is now trading at $2.18.
View the best growth stocks for 2022 here
.

How were Know Labs' earnings last quarter?

Know Labs, Inc. (OTCMKTS:KNWN) issued its earnings results on Wednesday, August, 7th. The company reported ($0.04) earnings per share (EPS) for the quarter. The firm had revenue of $0.38 million for the quarter.
View Know Labs' earnings history
.

Who are Know Labs' key executives?

Know Labs' management team includes the following people:
  • Mr. Ronald P. Erickson J.D., Founder, Chairman & Treasurer (Age 78, Pay $366.04k)
  • Mr. Phillip A. Bosua, CEO & Director (Age 48, Pay $663.76k)
  • Mr. Peter Joseph Conley, CFO & Sr. VP of Intellectual Property
  • Mr. Leo Trautwein, Chief Marketing Officer
  • Dr. James H. Anderson Jr., M.D., Chief Medical Officer and Chairman of Medical, Scientific & Regulatory Advisory Board
  • Mr. Steven T. Kent, Chief Product Officer
  • Mr. Masanori Takee, Sr. VP of Software Engineering

What other stocks do shareholders of Know Labs own?

What is Know Labs' stock symbol?

Know Labs trades on the OTCMKTS under the ticker symbol "KNWN."

How do I buy shares of Know Labs?

Shares of KNWN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Know Labs' stock price today?

One share of KNWN stock can currently be purchased for approximately $2.18.

How much money does Know Labs make?

Know Labs (OTCMKTS:KNWN) has a market capitalization of $95.49 million and generates $120 thousand in revenue each year. The company earns $-25.36 million in net income (profit) each year or ($0.76) on an earnings per share basis.

How many employees does Know Labs have?

Know Labs employs 12 workers across the globe.

How can I contact Know Labs?

Know Labs' mailing address is 500 UNION STREET SUITE 810, SEATTLE WA, 98101. The official website for Know Labs is www.knowlabs.co. The company can be reached via phone at (206) 903-1351, via email at [email protected], or via fax at 206-826-0451.

This page (OTCMKTS:KNWN) was last updated on 6/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.